Triangle-toothed gear occlude-guided universal nanotechnology constructs 3D symmetric DNA polyhedra with high assembly efficiency for precision cancer therapy
Journal of Colloid and Interface Science · 2025
DOI: 10.1016/j.jcis.2024.08.080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Colloid and Interface Science, 2025. Verfasst von Qian Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical…. Hauptthemen laut MEDLINE: DNA, Nanotechnology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chemotherapy is commonly used to treat malignant tumors. However, conventional chemotherapeutic drugs often cannot distinguish between tumor and healthy cells, resulting in adverse effects and reduced therapeutic efficacy. Therefore, zigzag-shaped gear-occlude-guided cymbal-closing (ZGC) DNA nanotechnology was developed based on the mirror-symmetry principle to efficiently construct symmetric DNA polyhedra. This nanotechnology employed simple mixing steps for efficient sequence design and assembly. A targeting aptamer was installed at a user-defined position using an octahedron as a model structure. Chemotherapeutic drug-loaded polyhedral objects were subsequently delivered into tumor cells. Furthermore, anticancer drug-loaded DNA octahedra were intravenously injected into a HeLa tumor-bearing mouse model. Assembly efficiency was almost 100 %, with no residual building blocks identified. Moreover, this nanotechnology required a few DNA oligonucleotides, even for complex polyhedrons. Symmetric DNA polyhedrons retained their structural integrity for 24 h in complex biological environments, guaranteeing prolonged circulation without drug leakage in the bloodstream and promoting efficient accumulation in tumor tissues. In addition, DNA octahedra were cleared relatively slowly from tumor tissues. Similarly, tumor growth was significantly inhibited in vivo, and a therapeutic outcome comparable to that of conventional gene-chemo combination therapy was observed. Moreover, no systemic toxicity was detected. These findings indicate the potential application of ZGC DNA nanotechnology in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy an…
- Department of Gastric Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, Q., He, T., Chen, L., Zhu, S., Li, C., Zeng, Y., Luo, S., Chen, S., Chen, X., Yu, S., Ye, Z., & Wu, Z. S. (2025). Triangle-toothed gear occlude-guided universal nanotechnology constructs 3D symmetric DNA polyhedra with high assembly efficiency for precision cancer therapy. Journal of Colloid and Interface Science. https://doi.org/10.1016/j.jcis.2024.08.080
Vancouver
Gao Q, He T, Chen L, Zhu S, Li C, Zeng Y, et al. Triangle-toothed gear occlude-guided universal nanotechnology constructs 3D symmetric DNA polyhedra with high assembly efficiency for precision cancer therapy. Journal of Colloid and Interface Science. 2025. doi:10.1016/j.jcis.2024.08.080
BibTeX
@article{Gao2025,
author = {Gao, Qian and He, Tenghang and Chen, Linhuan and Zhu, Shidan and Li, Congcong and Zeng, Yi and Luo, Shasha and Chen, Shu and Chen, Xiangru and Yu, Suhong and Ye, Zaisheng and Wu, Zai-Sheng},
title = {Triangle-toothed gear occlude-guided universal nanotechnology constructs 3D symmetric DNA polyhedra with high assembly efficiency for precision cancer therapy},
journal = {Journal of Colloid and Interface Science},
year = {2025},
doi = {10.1016/j.jcis.2024.08.080}
}
EUVIMED